Moderna (MRNA) president awarded major new option and RSU grants
Rhea-AI Filing Summary
Moderna, Inc. reported multiple equity transactions involving President Stephen Hoge. On March 1, 2026, he received a stock option covering 125,466 shares and a new award of 165,230 restricted stock units, each at an exercise or acquisition price of $0.00 per share. The new option and RSU awards begin vesting on March 1, 2027, with 25% vesting then and the remainder in twelve equal quarterly installments.
On February 27, 2026, several existing restricted stock unit awards were exercised, converting into common stock on a one-for-one basis. In connection with these vests, portions of the resulting shares were delivered at $51.71 per share to satisfy tax withholding obligations. Following these transactions, Hoge held 1,477,997 shares of common stock directly, plus additional indirect holdings of common stock by Valhalla, LLC and by a trust for his spouse and children, for which he disclaims beneficial ownership except for any pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 125,466 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 165,230 | $0.00 | -- |
| Exercise | Restricted Stock Units | 652 | $0.00 | -- |
| Exercise | Restricted Stock Units | 611 | $0.00 | -- |
| Exercise | Restricted Stock Units | 1,436 | $0.00 | -- |
| Exercise | Restricted Stock Units | 37,131 | $0.00 | -- |
| Exercise | Common Stock | 652 | $0.00 | -- |
| Tax Withholding | Common Stock | 316 | $51.71 | $16K |
| Exercise | Common Stock | 611 | $0.00 | -- |
| Tax Withholding | Common Stock | 296 | $51.71 | $15K |
| Exercise | Common Stock | 1,436 | $0.00 | -- |
| Tax Withholding | Common Stock | 695 | $51.71 | $36K |
| Exercise | Common Stock | 37,131 | $0.00 | -- |
| Tax Withholding | Common Stock | 17,953 | $51.71 | $928K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Restricted stock units convert into common stock on a one-for-one basis. Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. 25% of the shares subject to this restricted stock unit award vested on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter. 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. 25% of this option will vest and become exercisable on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter. 25% of the shares subject to this restricted stock unit award will vest on March 1, 2027 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
